Stocktoria
INTELLIGENT BIO SOLUTIONS INC. INBS
INTELLIGENT BIO SOLUTIONS INC. (INBS) earns a Piotroski F-score of 2/9 (weak financial health). It does not currently pay a dividend. FY2025 revenue was $3.1M at a -346.2% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.63 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| INBS | INTELLIGENT BIO SOLUTIONS INC. | 2/9 | — | — | — |
| OSRH | OSR Health, Inc. | — | 1.04 | — | — |
| AURX | Nuo Therapeutics, Inc. | 3/9 | — | — | — |
| USAQ | QHSLab, Inc. | 4/9 | -1.02 | — | — |
| FEMY | FEMASYS INC | 2/9 | — | — | — |
| TNON | Tenon Medical, Inc. | 4/9 | — | — | — |
| EBRCZ | EBR Systems, Inc. | 2/9 | -12.31 | — | — |
About INTELLIGENT BIO SOLUTIONS INC.
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
FAQ
Is INBS financially healthy?
INTELLIGENT BIO SOLUTIONS INC.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).
Does INBS pay a dividend?
No, INTELLIGENT BIO SOLUTIONS INC. does not currently pay a dividend.
How profitable is INBS?
In FY2025, INTELLIGENT BIO SOLUTIONS INC. had a net margin of -346.2% and a return on equity of -352.7%.
What is the analyst price target for INBS?
The average Wall-Street price target for INTELLIGENT BIO SOLUTIONS INC. is $12.00, about 372.4% above the recent price, from 1 analysts (consensus: strong buy).
Is INBS a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on INTELLIGENT BIO SOLUTIONS INC.: a Piotroski F-score of 2/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.